Vaso Corporation (VASO)
OTCMKTS · Delayed Price · Currency is USD
0.1740
+0.0040 (2.35%)
Jan 8, 2026, 10:38 AM EST
Vaso Corporation Market Cap
Vaso Corporation has a market cap or net worth of $29.91 million as of January 8, 2026. Its market cap has increased by 41.99% in one year.
Market Cap
29.91M
Enterprise Value
-2.92M
Revenue
89.11M
Ranking
n/a
PE Ratio
11.54
Stock Price
$0.17
Market Cap Chart
Since June 15, 1992, Vaso Corporation's market cap has decreased from 36.04M to 29.91M, a decrease of -17.01%. That is a compound annual growth rate of -0.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 29.91M | -2.80% |
| Dec 31, 2025 | 30.77M | 46.21% |
| Dec 31, 2024 | 21.05M | -60.64% |
| Dec 29, 2023 | 53.47M | 85.05% |
| Dec 30, 2022 | 28.90M | 202.47% |
| Dec 31, 2021 | 9.55M | -38.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Glass House Brands | 714.29M |
| Elite Pharmaceuticals | 516.25M |
| Northwest Biotherapeutics | 444.91M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 368.24M |
| Silence Therapeutics | 270.65M |